SNZ

Hinkal Closes Strategic Funding Round to Advance Discreet Trading and Position Liquidation

Retrieved on: 
Friday, April 26, 2024
Kraken, Decentralized finance, Coinbase, VCS, News, KYC, SNZ, Privacy, Knowledge, Confidentiality, Tim Draper, SAN, Cryptocurrency

The raise follows the close of Hinkal's $4.1M seed funding round in November of 2023.

Key Points: 
  • The raise follows the close of Hinkal's $4.1M seed funding round in November of 2023.
  • With surging demand from institutional clientele, this strategic funding will be used to bring liquid funds, VCs, family offices and founders of projects to Hinkal's confidential infrastructure.
  • This strategic funding round will allow us to accelerate the development and adoption of our groundbreaking privacy solution."
  • Audited by major firms including Quanstamp and Zokyo, Hinkal provides a secure trading experience and real-time threat mitigation with Hexagate.

Moondance Labs Announces $6 Million Funding to Boost Development of Tanssi Protocol

Retrieved on: 
Thursday, March 21, 2024
SNZ, Non-fungible token, Decentralized finance, Ecosystem, Cryptocurrency

TORTOLA, British Virgin Islands, March 21, 2024 /PRNewswire/ - Moondance Labs, the creators of the innovative Tanssi appchain infrastructure protocol, have announced a successful $6 million funding round.

Key Points: 
  • TORTOLA, British Virgin Islands, March 21, 2024 /PRNewswire/ - Moondance Labs, the creators of the innovative Tanssi appchain infrastructure protocol, have announced a successful $6 million funding round.
  • George McDonaugh, Managing Director and Co-Founder of KR1, shared his enthusiasm for Moondance Labs' progress over the last year.
  • The newly acquired funds are designated for team growth at Moondance Labs and the further refinement of Tanssi.
  • Reflecting on the funding milestone, Francisco Agosti, Co-founder of Tanssi and CEO of Moondance Labs, expressed his excitement about accelerating Tanssi's evolution.

Moondance Labs Announces $6 Million Funding to Boost Development of Tanssi Protocol

Retrieved on: 
Friday, March 22, 2024
SNZ, Decentralized finance, Ecosystem, Cryptocurrency

TORTOLA, British Virgin Islands, March 22, 2024 /PRNewswire/ -- Moondance Labs, the creators of the innovative Tanssi appchain infrastructure protocol, have announced a successful $6 million funding round.

Key Points: 
  • TORTOLA, British Virgin Islands, March 22, 2024 /PRNewswire/ -- Moondance Labs, the creators of the innovative Tanssi appchain infrastructure protocol, have announced a successful $6 million funding round.
  • George McDonaugh, Managing Director and Co-Founder of KR1, shared his enthusiasm for Moondance Labs' progress over the last year.
  • The newly acquired funds are designated for team growth at Moondance Labs and the further refinement of Tanssi.
  • Reflecting on the funding milestone, Francisco Agosti, Co-founder of Tanssi and CEO of Moondance Labs, expressed his excitement about accelerating Tanssi's evolution.

SphereX, a Decentralized Crypto Exchange, Secures Major Investment from SNZ, Strengthening Support

Retrieved on: 
Wednesday, February 28, 2024
Investment, SNZ, DEX, Ecosystem, Decentralized finance, Cryptocurrency

The investment from SNZ comes in addition to the substantial support already provided by Fundamental Labs , further validating SphereX's vision and mission within the rapidly evolving decentralized finance (DeFi) ecosystem.

Key Points: 
  • The investment from SNZ comes in addition to the substantial support already provided by Fundamental Labs , further validating SphereX's vision and mission within the rapidly evolving decentralized finance (DeFi) ecosystem.
  • SphereX aims to revolutionize decentralized trading by offering a seamless and intuitive platform that prioritizes user experience while maintaining the core principles of decentralization, security, and transparency.
  • The investment from SNZ underscores growing confidence in SphereX's innovative approach to decentralized trading.
  • With a strong foundation of support and a clear vision for the future, SphereX is poised to make a significant impact on the decentralized finance space.

Three New Articles in the Journal of Pharmaceutical Analysis Demonstrate the Potential of Natural Compounds to Treat Gastrointestinal Disorders

Retrieved on: 
Tuesday, November 28, 2023
Hepatitis, MEFV, Dave's Picks Volume 13, Hope, Pneumonia, Liver, HSP90, Panax notoginseng, Macrophage, Mouse, Journal, Colitis, Metabolism, Ulcerative colitis, Ethanol, GI, NLRP3, SNZ, ALD, UC, JPA, Pharmaceutical industry

XI'AN, China, Nov. 28, 2023 /PRNewswire/ -- Chronic gastrointestinal (GI) disorders are becoming increasingly common throughout the world, but many of them still lack effective treatment. Researchers have now turned to natural compounds, such as those present in traditional medicines, to search for potential drug candidates for difficult-to-treat diseases. The latest issue of the Journal of Pharmaceutical Analysis (JPA) features three articles that report promising findings and could pave the way to treatments for complex diseases affecting the liver and intestine. 

Key Points: 
  • Researchers have now turned to natural compounds, such as those present in traditional medicines, to search for potential drug candidates for difficult-to-treat diseases.
  • The latest issue of the Journal of Pharmaceutical Analysis (JPA) features three articles that report promising findings and could pave the way to treatments for complex diseases affecting the liver and intestine.
  • The article was available online in July 2023 and published in Volume 13, Issue 9 of JPA in September 2023 .
  • Moreover, Rk2 also restored intestinal barrier function by enhancing NLPR6 signaling in the intestine, demonstrating its multifaceted therapeutic potential.

Puffer Finance Raises $5.5M Seed Funding to Strengthen Ethereum Decentralization & Scalability

Retrieved on: 
Tuesday, August 8, 2023
Crypto, Blockchain, Partnership, ETH, Face, POS, Extended Validation Certificate, Business, LBK, SNZ, Concave, Trust, Mining pool, Risk, Kowloon Tong, GEORGE, Ecosystem, ROI, Software, Cryptocurrency, Ethereum, Puffer

Secure-Signer previously received support from the Ethereum Foundation in the form of a $120k grant, underscoring its importance within the Ethereum ecosystem.

Key Points: 
  • Secure-Signer previously received support from the Ethereum Foundation in the form of a $120k grant, underscoring its importance within the Ethereum ecosystem.
  • Commenting on the announcement, Amir Forouzani, and Jason Vranek, Founders of Puffer Finance, said: "The rapid advancements in infrastructure and user experience have primed Ethereum for mass adoption.
  • We hope the Puffer Protocol will create a pocket within the validator set where decentralization can thrive.
  • Together and with our community, we will build a flourishing ecosystem true to the values that made Ethereum so special."

Social Future Raised $6M to Build AI-Driven Virtual Social Platform

Retrieved on: 
Thursday, April 6, 2023
Social Media, Theme Parks, Mobile Entertainment, Technology, Communications, Blockchain, Professional Services, NFT, Artificial Intelligence, Digital Cash Management, Digital Assets, Web3, Metaverse, Electronic Games, Other Technology, Entertainment, Cryptocurrency, TEB, Animoca Brands, MPC, Life, 3D, UAW, Multimedia, Emotion, IP, Vance, SNZ, Creativity, Web 2.0, Collection, MAY, AI, Industrial design, Decentraland

Social Future, an AI-driven social metaverse company, is excited to announce that it has successfully raised $6 million in funding.

Key Points: 
  • Social Future, an AI-driven social metaverse company, is excited to announce that it has successfully raised $6 million in funding.
  • Social Future is also a member of OMA3 (Open Metaverse Alliance) , and partners with well-known metaverse companies such as Animoca Brands, Decentraland, and Metajuice.
  • Social Future aims to create the future of social experience with phygital interaction, immersive content, and self-sovereign communities.
  • Social Future's product, MAY ("Meet Another You") , enables immersive social experiences via personalized avatars.

FilSwan Raises $3M USD to Revolutionize & Simplify Building dApps

Retrieved on: 
Monday, January 16, 2023
Chain-link fencing, BNB, InterPlanetary File System, IPFS, Acquisition, Data science, SNZ, SAFT, Cryptocurrency, Web3, Polygon, DAPP

TORONTO, Jan. 16, 2023 /PRNewswire-PRWeb/ -- FilSwan, a cross-chain infrastructure for web3, is pleased to disclose three million US dollar fundraisings. FilSwan provides services that integrate data, computing, bandwidth, and payment into one suite for Web3 projects.

Key Points: 
  • FilSwan provides services that integrate data, computing, bandwidth, and payment into one suite for Web3 projects.
  • TORONTO, Jan. 16, 2023 /PRNewswire-PRWeb/ -- FilSwan , a cross-chain infrastructure for web3, is pleased to disclose three million US dollar fundraisings.
  • FilSwan provides services that integrate data, computing, bandwidth, and payment into one suite for Web3 projects.
  • A new project on decentralized data science, Lagrange DAO, is incubated by FilSwan and kicked off on Hack FEVM - ETHGlobal. "

Probiotic strain SNZ 1969® helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

Retrieved on: 
Tuesday, November 29, 2022
Poultry, Probiotic, Heartburn, Degenerative disease, Colon, Canadian International Council, Nausea, Apollo Hospitals, SNZ, Gastrointestinal tract, SODA, Fear, Irritable bowel syndrome, IBS, Pharmacology, Constipation, Health, Bacillus coagulans, Dietary supplement

HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ --Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms.

Key Points: 
  • HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ --Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms.
  • The outcome of this study will be significant to supplement manufacturers as it can help design products to address consumer need for managing IBS symptoms with a scientifically studied probiotic strain.
  • This study was conducted at Apollo Hospitals, Hyderabad, India and published in the International Journal of Basic & Clinical Pharmacology.
  • Intestinal motility study concluded that SNZ 1969 reaches the colon intact and ameliorates intestinal motility and gut microbiota composition.

Probiotic strain SNZ 1969® helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

Retrieved on: 
Tuesday, November 29, 2022
Poultry, Probiotic, Heartburn, Degenerative disease, Colon, Canadian International Council, Nausea, Apollo Hospitals, SNZ, Gastrointestinal tract, SODA, Fear, Irritable bowel syndrome, IBS, Pharmacology, Constipation, Health, Bacillus coagulans, Dietary supplement

HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ --Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms.

Key Points: 
  • HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ --Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969 (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms.
  • The outcome of this study will be significant to supplement manufacturers as it can help design products to address consumer need for managing IBS symptoms with a scientifically studied probiotic strain.
  • This study was conducted at Apollo Hospitals, Hyderabad, India and published in the International Journal of Basic & Clinical Pharmacology.
  • Intestinal motility study concluded that SNZ 1969 reaches the colon intact and ameliorates intestinal motility and gut microbiota composition.